Bristol-Myers Squibb (BMY) hired bankers to weigh a possible deal with Sanofi (SNY), the Financial Times reported.

The news comes just days after Bristol shares surged following a French newsletter report that the partners in blockbuster bloodthinner Plavix had signed a premerger agreement. Bankers denied that, the FT said.

The news comes as Bristol struggles under interim chief Jim Cornelius to overcome legal and operational questions left by his predecessor, Peter Dolan, who was cashiered late last year after botching talks aimed at licensing Plavix to a generic competitor.

Bristol-Myers hired Lehman Brothers, Citigroup and Morgan Stanley, the FT said, citing people familiar with the companies.

More from Investing

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Will Kraft Heinz Buy Pepsico or Mondelez?

Will Kraft Heinz Buy Pepsico or Mondelez?

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Why Starbucks Latest Data Reveal Should Worry Investors

Why Starbucks Latest Data Reveal Should Worry Investors

Starbucks Sets Latest Plan to Recaffeinate Shares

Starbucks Sets Latest Plan to Recaffeinate Shares